Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66,399,673
-
Total 13F shares
-
40,510,233
-
Share change
-
+1,267,109
-
Total reported value
-
$1,201,291,923
-
Put/Call ratio
-
197%
-
Price per share
-
$29.73
-
Number of holders
-
114
-
Value change
-
+$39,479,834
-
Number of buys
-
54
-
Number of sells
-
51
Institutional Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q4 2020
As of 31 Dec 2020,
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) was held by
114 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,510,233 shares.
The largest 10 holders included
NEA Management Company, LLC, JANUS HENDERSON GROUP PLC, PRIMECAP MANAGEMENT CO/CA/, RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), FEDERATED HERMES, INC., BAKER BROS. ADVISORS LP, WELLINGTON MANAGEMENT GROUP LLP, and MPM ASSET MANAGEMENT LLC.
This page lists
114
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.